ArticleNeurology2025
Patterns of Retinal Damage and Visual Long-Term Consequences in Patients With Idiopathic Intracranial Hypertension.
Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic Profile.Annals of neurology · 2026Article
- Idiopathic Intracranial Hypertension with and Without Papilledema: A Comparative Cohort Study.Brain sciences · 2026Article
- Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP-1 Receptor Agonists.Annals of clinical and translational neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesPersistent visual impairment is a feared complication of idiopathic intracranial hypertension (IIH). However, the structural and functional retinal changes beyond papilledema and their visual long-term consequences are less well studied. Therefore, we aimed to map patterns of structural and functional retinal damage according to papilledema severity to explain when and by what mechanisms patients with IIH lose vision.
methodsA prospective cohort study was conducted at 2 tertiary headache centers in Denmark from January 2018 to September 2022. Patients with suspected IIH were consecutively included. Eligibility criteria included clinical suspicion of IIH, age 18 years or older, and written informed consent. The standardized longitudinal diagnostic workup included a structured interview, neurologic and ophthalmologic investigation, lumbar puncture, magnetic resonance imaging, venography, routine blood samples, and diagnostic classification. The primary end point was mechanisms of retinal damage resulting in visual field and acuity impairment according to papilledema severity. A visual outcome score was designed using the desirability of outcome ranking approach.
resultsWe included 154 patients with IIH (149 women [96.8%], median age 28.0 [interquartile range 23.0-34.0] years). We found 2 different mechanisms of structural and functional retinal damage according to papilledema severity: (1) Impairment of the retinal nerve fiber layer: increasing papilledema severity was paralleled by increasing atrophy of the retinal nerve fiber layer and atrophy of the ganglion cell layer and resulted in peripheral scotomata without affecting visual acuity. (2) Macular impairment: grade 4 papilledema combined with macular edema, macular exudate, or disorganization of the inner retinal layer resulted in persisting reduction of visual acuity. Using modified desirability of outcome ranking, we proposed a score to predict visual outcome. The score correlated with papilledema severity (Spearman ρ = 0.30; DISCUSSION: Our findings suggest 2 different mechanisms of structural and functional retinal impairment depending on papilledema severity. A visual outcome score was proposed, and papilledema severity and disorganization of the inner retinal layer were identified as major predictors of persistent functional retinal impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.